
The study retrospectively analyzed serum levels of human epididymis protein 4 (HE4) in COVID-19 patients, categorizing them by severity. Critically ill patients exhibited significantly higher baseline HE4 levels compared to severe and mild cases. HE4 levels correlated with age, clinical parameters, and lung manifestations. Baseline HE4 independently indicated COVID-19 severity and served as an independent prognostic parameter for mortality. Non-survivors exhibited consistently higher HE4 levels. A pre-treatment HE4 level of ≥331.7 pmol/L effectively predicted a higher risk of mortality due to severe COVID-19 pneumonia.
Like
Save
Share